Previous studies demonstrate that reactive oxygen species (ROS) derived from NADPH oxidases are involved in Ang II-induced cardiac hypertrophy through a PI3-kinase-dependent pathway (Yao et al., 2008). The gene discussed is FMO5; the disease is cardiac hypertrophy.